saba glp 1 Nutratology Saba GEM – GLP-1 Metabolic

8 Challenges and Considerations in Multi-Agonist Therapy Despite their advantages, GLP-1-based therapies face several challenges in adolescent populations: Gastrointestinal Side Effects: Nausea, vomiting, diarrhea, and constipation are common adverse events, especially during dose escalation

Salomon JJ, Gausterer JC, Selo MA, Hosoya K-I, Huwer H, Schneider-Daum N, et al

"The source of your peptides matters as much as the peptide itself

So, pharmaceutical companies started investigating the use of GLP-1s for weight-management purposes, and the first GLP-1 weight-loss drug, Saxenda (liraglutide), was approved by FDA in 2014 (it was previously approved to treat diabetes under the name Victoza)

As stated, these medications help you eat less without feeling deprived

We'll prioritize you